Humacyte, Inc. (HUMA) Return on equity
Humacyte, Inc. (HUMA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-1313.4%FY2025
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1313.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More HUMA financial trends
HUMA RevenueHUMA Net incomeHUMA Net marginHUMA Gross profitHUMA Gross marginHUMA Operating incomeHUMA Operating marginHUMA Operating cash flowHUMA Free cash flowHUMA Capital expendituresHUMA Stock buybacksHUMA Dividends paidHUMA Total assetsHUMA Total liabilitiesHUMA Shareholders’ equityHUMA overview →